OptymEdge has appointed Amy Del Medico as senior director of [...]

Artificial intelligence is reshaping the pharmaceutical and healthcare industries, accelerating [...]

M42, a global health leader leveraging artificial intelligence, technology, and [...]

As debate continues over the cost and sustainability of GLP-1 [...]

New data presented at the Alzheimer’s Association International Conference 2025 [...]

New AI platform designed to support faster discovery, better study [...]

Investment led by aMoon will support US and EU commercialisation [...]

OMNY Health has reached a major milestone, announcing that its [...]

With growing debate over a potential ban on DTC TV [...]

Digital assessments designed to support earlier diagnosis, streamline Alzheimer’s trial [...]